Pure Biologics (Poland) Volatility
| PUR Stock | 14.00 0.22 1.60% |
Pure Biologics Splka maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14% return per unit of risk over the last 3 months. Pure Biologics Splka exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pure Biologics' Variance of 19.3, risk adjusted performance of (0.11), and Coefficient Of Variation of (632.84) to confirm the risk estimate we provide.
Pure |
Pure Biologics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Pure daily returns, and it is calculated using variance and standard deviation. We also use Pure's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Pure Biologics volatility.
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Pure Biologics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Pure Biologics at lower prices. For example, an investor can purchase Pure stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Pure Biologics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Pure Stock
Moving against Pure Stock
| 0.73 | DNP | Dino Polska SA | PairCorr |
| 0.63 | SAN | Banco Santander SA | PairCorr |
| 0.61 | CEZ | CEZ as | PairCorr |
| 0.35 | UCG | UniCredit SpA | PairCorr |
Pure Biologics Market Sensitivity And Downside Risk
Pure Biologics' beta coefficient measures the volatility of Pure stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Pure stock's returns against your selected market. In other words, Pure Biologics's beta of -1.11 provides an investor with an approximation of how much risk Pure Biologics stock can potentially add to one of your existing portfolios. Pure Biologics Splka exhibits very low volatility with skewness of 0.8 and kurtosis of 1.2. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Pure Biologics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Pure Biologics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Pure Biologics Splka Demand TrendCheck current 90 days Pure Biologics correlation with market (Dow Jones Industrial)Pure Beta |
Pure standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.41 |
It is essential to understand the difference between upside risk (as represented by Pure Biologics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Pure Biologics' daily returns or price. Since the actual investment returns on holding a position in pure stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Pure Biologics.
Pure Biologics Splka Stock Volatility Analysis
Volatility refers to the frequency at which Pure Biologics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Pure Biologics' price changes. Investors will then calculate the volatility of Pure Biologics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Pure Biologics' volatility:
Historical Volatility
This type of stock volatility measures Pure Biologics' fluctuations based on previous trends. It's commonly used to predict Pure Biologics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Pure Biologics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Pure Biologics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pure Biologics Splka Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Pure Biologics Projected Return Density Against Market
Assuming the 90 days trading horizon Pure Biologics Splka has a beta of -1.1114 indicatingMost traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pure Biologics or Pure sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pure Biologics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Pure Biologics Splka has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Pure Biologics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Pure Biologics Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Pure Biologics is -703.44. The daily returns are distributed with a variance of 19.44 and standard deviation of 4.41. The mean deviation of Pure Biologics Splka is currently at 3.27. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.73
α | Alpha over Dow Jones | -0.6 | |
β | Beta against Dow Jones | -1.11 | |
σ | Overall volatility | 4.41 | |
Ir | Information ratio | -0.18 |
Pure Biologics Stock Return Volatility
Pure Biologics historical daily return volatility represents how much of Pure Biologics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise accepts 4.4093% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7242% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Pure Biologics Investment Opportunity
Pure Biologics Splka has a volatility of 4.41 and is 6.13 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Pure Biologics Splka is lower than 39 percent of all global equities and portfolios over the last 90 days. You can use Pure Biologics Splka to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Pure Biologics to be traded at 15.4 in 90 days.Good diversification
The correlation between Pure Biologics Splka and DJI is -0.18 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pure Biologics Splka and DJI in the same portfolio, assuming nothing else is changed.
Pure Biologics Additional Risk Indicators
The analysis of Pure Biologics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Pure Biologics' investment and either accepting that risk or mitigating it. Along with some common measures of Pure Biologics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 0.6437 | |||
| Mean Deviation | 3.26 | |||
| Coefficient Of Variation | (632.84) | |||
| Standard Deviation | 4.39 | |||
| Variance | 19.3 | |||
| Information Ratio | (0.18) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pure Biologics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Pure Biologics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Pure Biologics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Pure Biologics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Pure Biologics Splka.
Additional Tools for Pure Stock Analysis
When running Pure Biologics' price analysis, check to measure Pure Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Biologics is operating at the current time. Most of Pure Biologics' value examination focuses on studying past and present price action to predict the probability of Pure Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Biologics' price. Additionally, you may evaluate how the addition of Pure Biologics to your portfolios can decrease your overall portfolio volatility.